Comparison of oral bioavailability of acetaminophen tablets, capsules and effervescent dosage forms in healthy volunteers

1. Santovena A, et al.: Formulation design of oral pediatric Acetazolamide suspension: dose uniformity and physico-chemical stability study. Pharm. Dev. Techn. 2017;22:191.Search in Google Scholar

2. Ubeda A, et al.: Blood pressure reduction in hypertensive patients after withdrawal of effervescent medication. Pharmacoepidemiol Drug Saf.2009;18:417.10.1002/pds.1701Open DOISearch in Google Scholar

3. Ferreira NN, et al.: A novel pH-responsive hydrogel-based on calcium alginate engineered by the previous formation of polyelectrolyte complexes (PECs) intended to vaginal administration. Drug Dev Ind Pharm. 2017;1.10.1080/03639045.2017.1328434Search in Google Scholar

4. Koen YM, et al.: Comparative Toxicity and Metabolism of N-Acyl Homologues of Acetaminophen and Its Isomer 3-Hydroxyacetanilide. Chem Res Toxicol 2016;29:1857.10.1021/acs.chemrestox.6b00270Search in Google Scholar

5. Anderson BJ: Paracetamol (Acetaminophen): mechanisms of action. Paediatr Anaesth. 2008;18:915.10.1111/j.1460-9592.2008.02764.xOpen DOISearch in Google Scholar

6. Preis M: Orally disintegrating films and mini-tablets-innovative dosage forms of choice for pediatric use. AAPS PharmSciTech. 2015;16:234.10.1208/s12249-015-0313-1Search in Google Scholar

7. Alam MT, et al.: FDA-Approved Natural Polymers for Fast Dissolving Tablets. J Pharm (Cairo). 2014;952970.10.1155/2014/952970Search in Google Scholar

8. Rawlins M, et al.: Pharmacokinetics of paracetamol (acetaminophen) after intravenous and oral administration. Eur J Clin Pharm. 1977;11:283.10.1007/BF00607678Search in Google Scholar

9. Srinath K, et al.: Formulation and evaluation of effervescent tablets of paracetamol. INT J Pharm Res Dev. 2011;3:76.Search in Google Scholar

10. Blagden N, et al.: Crystal engineering of active pharmaceutical ingredients to improve solubility and dissolution rates. Adv Drug Deliv Rev 2007 Jul 30;59(7):617-30 Epub 2007 May 29.10.1016/j.addr.2007.05.011Search in Google Scholar

11. De Silva L, et al.: Usability of mobile technology to screen for drugdrug interactions in kidney transplant patients. Am J Nephrol. 2014;40(2):97-104. doi: 101159/000364910 Epub 2014 Jul 19.10.1159/000364910Search in Google Scholar

12. Moes AJ: Gastroretentive dosage forms. Crit Rev Ther Drug Carrier Syst. 1993;10(2):143-95.Search in Google Scholar

13. Wilding II, et al.: Development of a new engineering-based capsule for human drug absorption studies. Pharm Sci Technol Today. 2000;3:385.10.1016/S1461-5347(00)00311-4Open DOISearch in Google Scholar

14. Lopes CM, et al.: Overview on gastroretentive drug delivery systems for improving drug bioavailability. Int J Pharm. 2016;510:144.10.1016/j.ijpharm.2016.05.01627173823Search in Google Scholar

15. Altman R, et al.: Advances in NSAID development: evolution of diclofenac products using pharmaceutical technology. Drugs. 2015;75:859.10.1007/s40265-015-0392-z444581925963327Search in Google Scholar

16. Sohi H, et al.: Taste masking technologies in oral pharmaceuticals: recent developments and approaches. Drug Dev Ind Pharm. 2004;30:429.10.1081/DDC-120037477Open DOISearch in Google Scholar